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Background: Palliative Care (PC) aims to improve the quality of life for patients with cancer and their families and
its benefits have been demonstrated by several studies. The objective of this systematic review is to assess the
integration of PC in the content of guidelines/pathways of adult cancer patients in Europe.
Methods: We included studies of adult patients with cancer published from 01/01/1995 and 31/12/2013 in Europe
in six languages. We searched nine electronic databases, hand-searched six journals and also performed citation
tracking. Studies were ranked using Emanuel’s Integrated Palliative Care (IPC) criteria, a tool containing 11 domains
to assess PC content in guidelines. Two reviewers screened the results and narrative synthesis has been employed.
Results: We identified a total of 28,277 potentially relevant articles from which 637 were eligible for full-text screening.
The final review included 60 guidelines and 14 pathways. Eighty percent (80 %) of the guidelines/pathways emphasize
a holistic approach and 66 % focus on PC interventions aimed at reducing suffering. Fifty seven percent (57 %) did not
discuss referral criteria for PC. Of all studies, five fulfilled at least 10/11 IPC criteria. Differences existed with regard to the
referral criteria for bereavement care and the continuous adjustment of goals of care.
Conclusion: Overall, most of the identified guidelines/pathways highlighted the importance of the holistic approach of
IPC. The studies that were found to fulfil at least 10/11 Emanuel’s IPC criteria could serve as benchmarks of IPC.
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According to EUROSTAT [1], cancer constitutes the sec-
ond most common cause of death in the European Union,
which amounts for 29 and 23 % of deaths for men and
women, respectively. Moreover, these numbers are expected
to increase as a result of the ageing of the population.
Palliative Care (PC) amounts to optimizing the quality
of life for patients and their families facing problems as-
sociated with cancer, and other life-threatening disease
more generally. In this framework, focus is placed on i)* Correspondence: naouma.siouta@ppw.kuleuven.com
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cation of treatment goals and iii) the support for both
patients and their families throughout the course of the
illness trajectory. Importantly, the effectiveness of pallia-
tive care on the improvement of the quality of life of
patients with advanced cancer has been corroborated by
an ever-growing bulk of research evidence [2–6].
Several health-care authorities and medical associa-
tions including the World Health Organization (WHO),
the European Society of Medical Oncology (ESMO), the
American Society of Clinical Oncology (ASCO), The
National Comprehensive Cancer Network (NCCN), The
European Association for Palliative Care (EAPC) and
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.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Table 1 Search terms used for the database search
(hospices OR supportive care OR supportive care* OR end of life
care* OR palliative* OR palliative care [MeSH Terms] OR hospice* OR
terminal care* OR coordinated care* OR integrated care* OR
transmural care* OR progressive patient care*) AND (“end stage
disease” OR end stage disease* OR dying OR death [MeSH Terms] OR
Chronic disease [MeSH Terms] OR Chronic disease* OR terminally ill*
OR terminally ill [MeSH Terms] OR cancer) AND (care pathway* OR
care pathway OR pathway* OR patient transfer* OR patient transfer
OR patient care team* OR managed care program* OR continuity of
patient care OR patient care management OR patient care plan* OR
patient care planning OR illness trajectory OR “advance care
planning” OR advance care planning OR delivery of health care OR
models of care OR model of care OR model organizational OR
models organizational OR organizational model* OR guideline*) NOT
((birth) OR child) OR pediatrics)) NOT ((animals[mh] NOT
humans[mh])) Filters: Publication date from 1995/01/01 to 2013/12/31
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trajectory [2, 7–13]. However, available studies report that,
at the end of life, patients with cancer usually receive sub-
optimal care [14], i.e. integration of PC remains limited. A
critical examination of the status quo in Europe reveals
that current European health-care delivery for patients
with cancer is suboptimal both from the quality-of-care
and from the financial perspective. In turn, this sub-
optimality is associated with a multitude of adverse effects,
a non-exhausting list of which includes: i) patients unable
to die at their place of preference [15–17], ii) large dis-
crepancies in treatment trajectories and (non)treatment
strategies in those with advanced cancer, indicating limited
consensus on optimal treatment pathways [18, 19] and iii)
considerable risks for overburdening of informal care-
givers, translating into an imbalance in care networks
surrounding the patient [20–23].
Central to the successful development and implemen-
tation of integrated PC strategies are the concepts of
guidelines and pathways. Guidelines are systematically
developed statements to assist practitioners and patient
decisions about appropriate health care for specific clin-
ical circumstances. They can be national, international
or local. As such, they are often used as a means to re-
duce variations in treatments within health-care systems,
to develop hospital-tailored protocols, to educate stu-
dents, to assist insurers etc., [24–26]. On the other hand,
a care pathway is defined as a complex intervention for
the mutual decision making and organisation of care
processes for a well-defined group of patients during a
well-defined period. A pathway may use guidelines to
provide clinical care.
The objective of the present study is to identify existing
guidelines and pathways of integrated PC for people with
cancer in the European Union and evaluate their com-
pleteness of content regarding their level of PC integration
by conducting a systematic review of the available
literature.
Methods
Despite the fact that there is a growing awareness of in-
tegrated palliative care (IPC) a unanimously agreed def-
inition for it does not exist. For the scopes of this study,
the InSup-C experts developed a consensus based defin-
ition that reads:
“Integrated palliative care involves bringing together
administrative, organisational, clinical and service
aspects in order to realise continuity of care between
all actors involved in the care network of patients
receiving palliative care. It aims to achieve quality of
life and a well-supported dying process for the patient
and the family in collaboration with all the care givers
(paid and unpaid)”.Search strategy
The following databases were searched electronically:
The Cochrane Central Register of Controlled Trials
(CENTRAL), PubMed, EMBASE, CINAHL, AMED,
British Nursing index (BNI), Web of Science, National
Guidelines Clearinghouse and NHS Evidence. The
search in the databases was performed using judiciously
chosen keywords and search terms as well as their
permutations/combinations. The basic search terms and
keywords that were used in the electronic databases are
presented in Table 1.
Additionally, the following journals were hand-
searched: BMJ Supportive & Palliative care, European
Journal of Palliative Care, Journal of Pain and Symptom
Management, Palliative Medicine, Medicina Paliativa
and the references from the included guidelines/
pathways.
The grey literature search consisted of two parts. For
the first part, named individuals within national scien-
tific medical organizations, were contacted with the aim
of gathering information on guidelines and pathways.
Examples of professional organizations included national
bodies for oncology and palliative care development.
The second part consisted of a grey literature search in-
volving an electronic search in Google. For this search,
the search strategy was translated in the languages of the
authors participating in this study.
Selection criteria
As mentioned in the introduction, this study is performed
in the context of the InSup-C research project. For this
reason, in compliance with the project’s objectives this
review is geographically limited in Europe. Further, the
following inclusion criteria were used:
1. Guidelines and pathways for adult patients.
2. Guidelines and pathways for cancer (latest possible
versions).
3. European guidelines and pathways.
Van Beek et al. BMC Palliative Care  (2016) 15:26 Page 3 of 174. Guidelines and pathways published from 01-01-1995
to 31-12-2013 (with the start date based on the pub-
lication of the Calman-Hine report which constitutes
the first national cancer plan in Europe [27]).
5. Languages: English, French, German, Dutch,
Hungarian and Spanish (the languages of the
authors)
To distinguish between studies focusing on PC from
those focusing on IPC, a sixth eligibility criterion is
needed. In the present study, we measure the complete-
ness of the IPC content of the guidelines/pathways via a
tool based on Emanuel’s IPC criteria. This is a template
designed by the American Hospice Foundation Guide-
lines Committee to provide a practical approach for
guideline writers and others to integrate PC into disease
management and care services whenever it is relevant
[28]. These criteria are described in Table 2. For the
needs of the present study, and following a consensus in
the InSup-C consortium, a guideline/pathway is consid-
ered to focus on IPC if it fulfils at least two out of the 11
criteria. Therefore, guidelines/pathways that fulfilled at
most one criterion were labelled as non-eligible.
It is important to note that, to the best of our know-
ledge, Emanuel’s criteria constitute the only tool that
evaluates the content of the guidelines/pathways regard-
ing the level of PC integration. Consequently, even
though this tool has not been empirically validated, it
has been chosen as the best choice.Selection procedure
In the first phase, the first two authors (KVB and NS)
screened all the English search results based on their
titles and their abstract. Non English texts were screened
and translated by two native speaker researchers. Then
the full texts of the guidelines/pathways selected by both
authors were sourced and they were reviewed based
on the aforementioned inclusion/exclusion criteria.Table 2 Integrated Palliative Care (IPC) Criteria
1. Discussion of illness limitations and prognosis.
2. Recommendations for conducting a whole patient assessment
including the patient’s physical, social, psychological, and spiritual
issues, their family and community setting.
3. Recommendations for when to make these assessments (e.g. At
baseline and periodically thereafter).
4. Recommendations on when palliative care should be integrated.
5. Assessment of the patient’s goals for care.
6. Continuous goal adjustment as the illness and the person’s disease
progresses.
7. Palliative care interventions to reduce suffering as needed.
8. Advance care planning.
9. Recommendation of involving a palliative care team (interdisciplinary
team, palliative care consultation or other palliative care services).
10. Recommendations on care during the last hours of living.
11. Recommendations on grief and bereavement care.Discrepancies were resolved by consensus or they were
extensively discussed in consecutive project meetings.
Data extraction
Data were extracted from guidelines/pathways meeting
the inclusion criteria using a data extraction form. This
form was based on the extraction form described in
Hawker et al. [29], but it was adjusted accordingly to the
purposes of our study after consensus in the project
meetings. For each included paper, data extraction was
carried out by the two first authors independently for
the English results and by two native speaker researchers
for the non-English ones. Upon the completion of the
process, the two reviewers cross-checked their results
and reached consensus in case of discrepancies.
Evidence quality assessment
In order to assess the quality of the evidence of the
guideline/pathways, we employed the following method-
ology. Guidelines/pathways that were based on both sys-
tematic reviews and consensus methods (e.g. nominal
group techniques, Delphi rounds, expert consultations)
or those developed by following the NICE protocol [30]
were considered high quality evidence; guidelines/path-
ways based on systematic review only or based on other
types of well referenced evidence were considered
medium quality whereas those based on consensus
methods only were considered low quality. Finally,
guidelines/pathways whose basis was unclear (e.g. appar-
ently evidence based but failing to clarify how this was
obtained) were considered of very low quality. This qual-
ity assessment guide was agreed upon during consensus
between the authors.
Data synthesis
The included studies are characterized by a substantial
heterogeneity. For this reason, a narrative synthesis has
been considered appropriate and results have tabulated
in easily accessible tables (Tables 3 and 4).
Results
We identified a total of 28,277 potentially relevant doc-
uments/records, of which 24,794 were excluded based
on their titles or abstracts. No additional articles were
identified through consultation with experts and na-
tional health organizations. An additional 3021 relevant
papers were identified from the hand-searched journals,
citation tracking and the grey literature, of which 2905
were not eligible for full text screening. Full-text review
was performed on the remaining 521 articles from the
electronic database search and 116 articles from the
other sources mentioned above. The final review in-
cluded 74 papers of which 60 were guidelines [31–90]
and 14 pathways [91–104]. The characteristics of these
Table 3 Characteristics of included Cancer Guidelines
Cancer guidelines
Title/Country/Year Setting Emanuel’s criteria (EMC) Quality of
evidence
Interdisciplinary guideline of quality
for early detection, diagnosis and
treatment of different stages of
prostate cancer/Germany/2011. [31]
inpatient/
outpatient
7 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Suffering reduction, ACP, Involvement of PC team.
High
Practice guideline for palliative care/
Germany/2009. [32]
outpatient 9 EMC: Holistic assessments, Timing of PC introduction,
Patient’s goals, Continuous goal adjustment, Suffering
reduction, ACP, Involvement of PC team, Last hours of
living care, Grief and bereavement care.
Low
Interdisciplinary guidelines for the
diagnosis, treatment and follow-up of
breast cancer/Germany/2012. [33]
inpatient/
outpatient
9 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Continuous
goal adjustment, Suffering reduction, Involvement of
PC team, Last hours of living care.
High
Guideline: Prevention, Diagnosis,
Therapy, and Follow-up of Lung
Cancer. (Germany, 2010) [34]
inpatient/
outpatient
9 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Continuous goal adjustment, Suffering reduction,
ACP, Involvement of PC team, Last hours of living care.
High
Malignant melanoma S3-guideline:
Diagnosis, treatment and aftercare
of melanoma. (Germany, 2013) [35]
inpatient/
outpatient
7 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Suffering reduction, ACP,
Involvement of PC team.
High
Cancer pain. (Germany, 2007) [36] inpatient/
outpatient
3 EMC: Holistic assessments, Timing of holistic assessments,
Continuous goal adjustment.
High
Directive of the Federal Joint
Committee on the Regulation of
specialized outpatient palliative
care. (Germany, 2007). [37]
outpatient 6 EMC: Holistic assessments, Patient’s goals, Suffering
reduction, ACP, Involvement of PC team, Last hours of
living care.
Very low
National Practice Guideline pancreatic
cancer. (Belgium, 2009) [38]
inpatient 3 EMC: Holistic assessments, Timing of PC introduction,
Involvement of PC team.
High
Small cell and non- small cell lung
cancer: diagnosis, treatment and
follow-up. (Belgium, 2013) [39]
inpatient 2 EMC: Patient’s goals, ACP. High
National Practice Guideline of
oesophageal and stomach cancer –
UPDATE. (Belgium, 2012) [40]
inpatient 4 EMC: Holistic assessments, Timing of PC introduction,
Suffering reduction, Involvement of PC team.
High
Palliative Care Unit: Standards and
Recommendations. (Spain, 2009) [41]
inpatient/
outpatient
8 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Suffering reduction, ACP, Involvement of PC team,
Grief and bereavement care.
High
Clinical Practice Guidelines on
Palliative Care. (Spain, 2008) [42]
inpatient/
outpatient
10 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Continuous goal adjustment, Suffering reduction,
ACP, Involvement of PC team, Last hours of living care,
Grief and bereavement care.
High
Palliative Care Guideline.
(Spain, no date available) [43]
inpatient/
outpatient
3 EMC: Involvement of PC team, Last hours of living care,
Grief and bereavement care.
Very low
Palliative Care Guideline in the
Community of Madrid.
(Spain, 2008) [44]
inpatient/
outpatient
5 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Suffering
reduction, Last hours of living care.
Very low
Clinical recommendations guideline:
colorectal cancer. (Spain, 2006). [45]
4 EMC: Holistic assessments, Timing of PC introduction,
Continuous goal adjustment, Grief and bereavement care.
High
Guideline Care in the dying phase.
(The Netherlands, 2010) [46]
inpatient/
outpatient
8 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Suffering reduction, ACP, Last hours of living care,
Grief and bereavement care.
Low
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Guideline Leptomeningeal metastases.
(The Netherlands, 2010) [47]
inpatient/
outpatient
4 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Suffering
reduction.
High
Guideline Oncologic Rehabilitation.
(The Netherlands, 2011) [48]
inpatient/
outpatient
6 EMC: Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Continuous goal
adjustment, Suffering reduction.
Medium
Guideline NSCLC.
(The Netherlands, 2011). [49]
inpatient/
outpatient
5 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Patient’s goals, Suffering reduction.
High
Guideline Melanoma.
(The Netherlands, 2013) [50]
inpatient/
outpatient
3 EMC: Discussion of illness limitations and prognosis,
Timing of PC introduction, Suffering reduction.
High
Guideline Oesophagus carcinoma.
(The Netherlands, 2010) [51]
inpatient/
outpatient
8 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Continuous
goal adjustment, Suffering reduction, ACP.
High
Guideline Pancreas carcinoma.
(The Netherlands, 2011) [52]
inpatient/
outpatient
3 EMC: Discussion of illness limitations and prognosis,
Patient’s goals, Suffering reduction.
High
Guideline cervix carcinoma.
(The Netherlands, 2012) [53]
inpatient/
outpatient
4 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Suffering reduction, ACP, Involvement
of PC team.
High
Guideline Endometrial carcinoma.
(The Netherlands, 2011) [54]
inpatient/
outpatient
2 EMC: Discussion of illness limitations and prognosis,
Involvement of PC team.
High
Guideline Sarcoma carcino-sarcoma uterus.
(The Netherlands, 2010) [55]
inpatient/
outpatient
2 EMC: Holistic assessments, Involvement of PC team. Low
Guideline Hypo-pharynx carcinoma.
(The Netherlands, 2010) [56]
inpatient/
outpatient
5 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Suffering reduction.
High
Guideline Larynx carcinoma.
(The Netherlands, 2010) [57]
inpatient/
outpatient
5 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Suffering reduction.
High
Guideline Mouth and oropharynx carcinoma.
(The Netherlands, 2004) [58]
inpatient/
outpatient
5 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Suffering reduction.
High
Guideline Breast cancer.
(The Netherlands, no date available) [59]
inpatient/
outpatient
4 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Suffering reduction.
High
Guideline Prostate carcinoma.
(The Netherlands, 2007) [60]
inpatient/
outpatient
3 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Patient’s goals.
High
Professional Guideline (Directive) of the
Hungarian Public Healthcare.
(Hungary, 2013) [61]
inpatient 10 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Patient’s goals, Continuous goal adjustment, Suffering
reduction, ACP, Involvement of PC team, Last hours of
living care, Grief and bereavement care.
Medium
Recommendations for the development
of an integrative and complex palliative
care in Hungary. (Hungary, 2013) [62]
inpatient/
outpatient
8 EMC: Discussion of illness limitations and prognosis,
Timing of holistic assessments, Timing of PC introduction,
Patient’s goals, Continuous goal adjustment, Suffering
reduction, ACP, Grief and bereavement care.
High
Guidance on Cancer Services: Improving
Supportive and Palliative Care for Adults
with Cancer. (UK, 2004) [63]
inpatient/
outpatient
9 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Patient’s goals, Suffering reduction, ACP, Involvement
of PC team, Last hours of living care, Grief and
bereavement care.
High
Making good care better: National practice
statements for general palliative care in
adult care homes in Scotland.
(UK-Scotland, 2006) [64]
outpatient 8 EMC: Holistic assessments, Patient’s goals, Continuous
goal adjustment, Suffering reduction, ACP, Involvement
of PC team, Last hours of living care, Grief and
bereavement care.
Low
The diagnosis and treatment of lung
Cancer-updated. (UK, 2011) [65]
inpatient 4 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Suffering reduction.
High
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Head and Neck Cancer: Multidisciplinary
Management Guidelines. (UK, 2011) [66]
inpatient/
outpatient
7 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Patient’s goals, Continuous goal
adjustment, Suffering reduction, Involvement of PC
team, Last hours of living care.
High
Guidelines for supportive care in multiple
myeloma 2011. (UK, 2011) [67]
inpatient 4 EMC: Holistic assessments, Timing of holistic assessments,
Suffering reduction, ACP, Last hours of living care.
High
The NICE Guidance on Supportive and
Palliative Care Implications for Oncology
Teams. (UK, 2004) [68]
inpatient 5 EMC: Holistic assessments, Patient’s goals, Suffering
reduction, Involvement of PC team, Grief and bereavement
care.
High
Metastatic malignant disease of unknown
primary origin. Diagnosis and management
of metastatic malignant disease of
unknown primary origin. (UK, 2010) [69]
inpatient 3 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Continuous goal adjustment.
High
Palliative and End of Life Care Indicators.
(UK-Scotland, 2013) [70]
inpatient/
outpatient
3 EMC: Discussion of illness limitations and prognosis,
Patient’s goals, ACP.
Low
Core competencies in palliative care: an
EAPC White Paper on palliative care
education. Parts 1 & 2. (UK, 2013) [71]
inpatient/
outpatient
8 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Patient’s goals, Continuous goal adjustment, ACP,
Involvement of PC team, Grief and bereavement care.
Low
Dying well at home: the case for integrated
working: Guide 48. (UK, 2013) [72]
inpatient/outpatient 7 EMC: Holistic assessments, Patient’s goals, Suffering
reduction, ACP, Involvement of PC team, Last hours of
living care, Grief and bereavement care.
Low
RCGP commissioning guidance in end of
life care : guidance for GPs, clinical
commissioning group advisers. (UK, 2013) [73]
inpatient/outpatient 7 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Patient’s goals, Continuous goal
adjustment, Involvement of PC team, Last hours of
living care, Grief and bereavement care.
Low
Optimising the role and value of the
interdisciplinary team: providing person
centred end of life care. (UK, 2013) [74]
inpatient/outpatient 9 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Patient’s goals, Continuous goal adjustment, ACP,
Involvement of PC team, Last hours of living care,
Grief and bereavement care.
Low
Strategy for adult palliative and end of life
care services. (UK, 2013) [75]
inpatient/outpatient 8 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Patient’s goals, Continuous goal
adjustment, Suffering reduction, Involvement of PC team,
Last hours of living care, Grief and bereavement care.
Low
End of Life Care Strategy: Fourth Annual
Report. (UK, 2012) [76]
inpatient/outpatient 3 EMC: ACP, Last hours of living care, Grief and
bereavement care.
High
Matters of life and death: helping people to
live well until they die. General practice
guidance for implementing the RCGP/RCN
end of life care patient charter. (UK, 2012) [77]
inpatient/outpatient 11 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments, Timing
of PC introduction, Patient’s goals, Continuous goal
adjustment, Suffering reduction, ACP, Involvement of PC
team, Last hours of living care, Grief and bereavement care.
High
End of life care for adults in the Emergency
Department. (UK, 2012) [78]
inpatient 4 EMC: Discussion of illness limitations and prognosis,
Timing of PC introduction, ACP, Involvement of PC team.
High
CMG42 End of life care for adults.
(UK, 2011) [79]
inpatient/outpatient 11 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments, Timing
of PC introduction, Patient’s goals, Continuous goal adjustment,
Suffering reduction, ACP, Involvement of PC team, Last hours
of living care, Grief and bereavement care.
High
Commissioning guidance for specialist
palliative care : helping to deliver
commissioning objectives. (UK, 2012) [80]
inpatient/outpatient 6 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, ACP, Involvement of PC team.
Low
Commissioning person centred end of life
care. (UK, 2012) [81]
inpatient/outpatient 2 EMC: ACP, Involvement of PC team. Low
Quality standard for end of life care for
adults. (UK, 2011) [82]
inpatient/outpatient 8 EMC: Holistic assessments, Timing of holistic assessments,
Patient’s goals, Continuous goal adjustment, ACP, Involvement
of PC team, Last hours of living care, Grief and bereavement
care.
High
Advanced breast cancer: Diagnosis and
treatment. (UK, 2009) [83]
inpatient/outpatient 3 EMC: Holistic assessments, Timing of holistic assessments,
Involvement of PC team.
High
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Review of palliative care services in
Scotland. (UK-Scotland, 2008) [84]
inpatient/outpatient 4 EMC: Holistic assessments, Patient’s goals, ACP,
Involvement of PC team.
High
Living and Dying Well: A national action
plan for palliative and end of life care in
Scotland. (UK-Scotland, 2008) [85]
inpatient/
outpatient
8 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Suffering
reduction, ACP, Involvement of PC team.
Low
Metastatic spinal cord compression:
Diagnosis and management of patients
at risk of or with metastatic spinal cord
compression. (UK, 2008) [86]
inpatient/
outpatient
2 EMC: Holistic assessments, Involvement of PC team. High
End of life care. (UK, 2008) [87] inpatient/
outpatient
5 EMC: Holistic assessments, Patient’s goals, ACP,
Last hours of living care, Grief and bereavement care.
Medium
National Care Standards: Hospice
Care. (UK, 2005) [88]
inpatient/
outpatient
2 EMC: Last hours of living care, Grief and bereavement
care.
Low
Clinical Standards: Specialist palliative
care. (UK, 2002) [89]
inpatient 7 EMC: Discussion of illness limitations and prognosis,
Holistic assessments, Patient’s goals, Continuous goal
adjustment, ACP, Involvement of PC team, Grief and
bereavement care.
Low
Improving outcomes in gynaecological
cancer: The Manual. (UK, 1999) [90]
inpatient/outpatient 2 EMC: Holistic assessments, Suffering reduction. High
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of the selection procedure and results (using the
PRISMA tool [105]) is shown in Fig. 1.
Of the 60 guidelines included in the final review, 28
guidelines originated from the UK, seven from Germany,
three from Belgium, five from Spain, 15 from the
Netherlands and two from Hungary. Additionally, four
pathways originated from the UK and Spain, three from
the Netherlands and one from Belgium, Germany and
Hungary. Twenty eight guidelines and five pathways can
be considered as cancer specific (e.g. breast cancer
guidelines, lung cancer guidelines, etc.). Four guidelines
deal with general oncology, 11 guidelines and three
pathways with the dying phase for patients with cancer
and chronic disease, 16 guidelines and six pathways with
PC in general and one guideline is about general health
care. It is important to note here, that the guidelines/
pathways focused on general PC and general health care
are not irrelevant to the scopes of this systematic review
because they are concerned with patients with cancer. In
this respect, these guidelines/pathways fulfil the inclu-
sion criterion on the type of the disease and as such they
are included in the study. Further information on these
guidelines and pathways is presented in Tables 3 and 4.
Looking at the results of the quality assessment of the
evidence, we have to stress that the assessment
employed in the present systematic review does not as-
sess the quality of the implementation of the included
guidelines/pathways. Rather, it provides a means of
evaluating the principles upon which they have been
developed. Very low quality guidelines/pathways corre-
sponded to only 11 % of the total number. Guidelines/
pathways with low quality were 27 %. Only a handful ofstudies (7 %) were categorised as medium quality. Fi-
nally, the majority of the included guidelines/pathways
(55 %) were classified as of high quality evidence.
The assessment of the palliative care content of the
guidelines/pathways via the IPC criteria revealed the fol-
lowing information. Nearly 80 % of the studies placed
particular emphasis on the holistic approach, namely the
assessment of the patient’s physical, psychological, social
and spiritual issues, although only half of these recom-
mendations (37 %) specified the exact timing on when
these holistic assessments should take place. Of all
guidelines/pathways, 47 % reported on the timing at
which palliative care should be integrated. An additional
66 % of the guidelines/pathways focused on palliative
care interventions aimed at reducing suffering. Interest-
ingly, 75 % of the included guidelines/pathways referred
to both an inpatient and an outpatient PC setting, as op-
posed to 16 and 8 % that referred solely to an inpatient
and an outpatient PC setting, respectively. Moreover,
55 % of the guidelines/pathways explicitly put emphasis
on discussion of illness limitations and prognosis and
55 % elaborated on the assessment of the patient’s goals
for care.
Just less than half of the included guidelines/pathways
paid attention to aspects of advance care planning
(46 %) and grief and bereavement care (40 %). Further-
more recommendations for continuous goal adjustment
(38 %), recommendations of care during the last hours
of life (47 %) and recommendations for the involvement
of a palliative care team (58 %), were mixed.
Guidelines and pathways that achieved a high score
using the IPC criteria were judged to comprehensively
address the core components of IPC. Two guidelines
Table 4 Characteristics of included Cancer Pathways
Cancer pathways
Title/Country/Year Setting Emanuel’s criteria (EMC) Quality of evidence
Palliative Medicine: Essays - Reports -
Discussion Posts - Comments: Liverpool
Care Pathway Practical assistance.
(Germany, 2008) [91]
inpatient 7 EMC: Holistic assessments, Timing of PC
introduction, Patient’s goals, Continuous goal
adjustment, Suffering reduction, ACP, Last
hours of living care.
Very low
Practice and opportunities of the
Hungarian hospice care provided at
home. (Hungary, 2013) [92]
Inpatient/outpatient 8 EMC: Discussion of illness limitations and
prognosis, Holistic assessments, Timing of
holistic assessments, Timing of PC introduction,
Patient’s goals, Continuous goal adjustment,
Suffering reduction, Last hours of living care.
Low
Palliative care pathway in General Practice.
(Belgium, 2012) [93]
outpatient 11 EMC: Discussion of illness limitations and
prognosis, Holistic assessments, Timing of
holistic assessments, Timing of PC introduction,
Patient’s goals, Continuous goal adjustment,
Suffering reduction, ACP, Involvement of PC
team, Last hours of living care, Grief and
bereavement care.
High
Integrated Oncological Pathways: prostate
carcinoma. (The Nederlands, 2010) [94]
inpatient/outpatient 5 EMC: Discussion of illness limitations and
prognosis, Holistic assessments, Suffering
reduction, Involvement of PC team, Last
hours of living care.
Medium
Integrated Oncological Pathways: colon-rectum
carcinoma. (The Nederlands, 2010) [94]
inpatient/outpatient 4 EMC: Timing of PC introduction, Suffering
reduction, Involvement of PC team, Last
hours of living care.
High
Flow chart glioblastoma.
(The Nederlands, 2012) [96]
inpatient/outpatient 4 EMC: Timing of holistic assessments, Timing
of PC introduction, Involvement of PC team,
Last hours of living care.
Very Low
Manual for the management of patients in
palliative care in outpatient ER.
(Spain, 2011) [97]
outpatient 4 EMC: Discussion of illness limitations and
prognosis, Timing of PC introduction, Suffering
reduction, Last hours of living care.
Low
Home care program in primary care.
(Spain, 2004) [98]
outpatient 6 EMC: Holistic assessments, Timing of PC
introduction, Suffering reduction, Involvement
of PC team, Last hours of living care, Grief and
bereavement care.
Very low
Integrated care process of Palliative Care.
(Spain, 2007) [99]
inpatient/outpatient 7 EMC: Holistic assessments, Timing of PC
ntroduction, Suffering reduction, ACP, Involvement
of PC team, Last hours of living care, Grief and
bereavement care.
High
Palliative care in the oncologic patient.
Documents for integrated care processes
related to cancer management.
(Spain, 2005) [100]
inpatient/outpatient 4 EMC: Holistic assessments, Suffering reduction,
Involvement of PC team, Grief and bereavement care.
Very low
Care pathway for the last days of life.
(UK-Wales, 2004) [101]
inpatient 8 EMC: Holistic assessments, Patient’s goals,
Continuous goal adjustment, Suffering reduction,
ACP, Involvement of PC team, Last hours of living
care, Grief and bereavement care.
Very low
The route to success in end of life care:
achieving quality for social work.
(UK, 2012) [102]
inpatient/outpatient 8 EMC: Holistic assessments, Patient’s goals,
Continuous goal adjustment, Suffering reduction,
ACP, Involvement of PC team, Last hours of living
care, Grief and bereavement care.
Low
Quality in melanoma care: a best practice
pathway. (UK, 2012) [103]
inpatient/outpatient 4 EMC: Holistic assessments, Patient’s goals, ACP,
Involvement of PC team.
High
Derbyshire End of Life Care Guidance: a
pathway for supporting people in the
last year of life. (UK, 2010) [104]
inpatient/outpatient 8 EMC: Holistic assessments, Timing of holistic
assessments, Patient’s goals, Suffering reduction,
ACP, Involvement of PC team, Last hours of living
care, Grief and bereavement care.
Low
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Fig. 1 Flow diagram of study selection procedure
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scored 10/11. These five studies were also ranked as of
high quality evidence which means that they were devel-
oped based on both consensus and literature review. Of
interest is that these five studies are not specific oncol-
ogy guidelines, but PC or End of Life Care guidance.
The guidelines/pathways that scored 10 or 11/11 are
presented and analysed in Table 5 and the strategies that
they propose can be summarised as follows:
1) Discussion of illness limitations and prognosis: The
guidelines/pathways agree that this can be realized
through open and honest communication with
patient and family, based on their needs and
preferences, and enabling shared decision making.
One pathway also suggests the employment of the
surprise question or the Palliative Performance Scale
can be used as triggers for initiating such
discussions.
2) Holistic assessment: There is a unanimous
consensus on the utilization of a combined physical,
psychological, social and spiritual assessment.
3) Timing of the holistic assessments: Assessment
should take place early in the disease trajectory.
Further, it is recommended that holistic assessment
should occur “at any time of day or night” for
physical and psychological support and as long as
possible for patient’s social participation. Also, its
realization should vary depending on changes in the
disease or on the appearance of new symptoms and
based on application of e.g. a ‘distress thermometer’.4) Exact timing of introducing PC: Three strategies are
identified: i) the use of the surprise question, ii) the
evaluation of the patient’s and the family’s needs, iii)
illness stage – disease/cancer related prognostic
indicators (e.g. like the indicators mentioned in the
Gold Standards Framework).
5) Patient’s goals assessments: All the guidelines/
pathways agree that this assessment should be based
on the continuous communication between the
patient and the PC specialists to identify patient
goals.
6) Continuous goal adjustment: It is suggested that PC
specialists regularly consult the patient and adjust
goals accordingly.
7) Suffering reduction: The guidelines/pathways
elaborate on the use of appropriate medication and
strategies aimed in reducing both physical and
psychological suffering.
8) Advance care planning (ACP): Decision making
should be based on patient’s wishes and preferences.
One pathway proposes the identification of the ACP
via the use of three models (covenant model,
contract model or DNR code).
9) Involvement of PC team: All of the guidelines/
pathways strongly recommend the involvement or
formation of a multidisciplinary PC team (consisting
of physicians, nurses and other health professionals,
psychologists, mental health counsellors, social
workers, spiritual counsellors).
10)Care during the last hours of living: The following
steps are recommended: identification of the dying
Table 5 Top 5 ICP guidelines and pathways
IPC criteria Clinical practice
guidelines on palliative
Care-Spain [42].
Guideline on the
palliative care
-Hungary [61].
Palliative care pathway
in General Practice
Country- Belgium [93].
General guidance
RCGP/RCN- UK [77].
CMG42 End of life care
for adults-UK [79].
Discussion of
illness limitations
and prognosis.
Communication should
be based on patients’
and their family‘s needs
rather than the expected
survival time.
Information about the
illness, decision
making, and
discussions about
death should be
based on the
patient’s needs.
Description of surprise
question and Palliative
Performance Scale (PPS)
to define prognosis or
when to enter PC
services.
Open and honest
communication.
Identification of triggers
for discussion. Shared
decision making.
Open communication
and offering of
information taking in
account always the
patient’s and family’s
needs.
Holistic
assessment.
Integral, frequent
assessment in a
multidisciplinary,
individualized manner
for: symptoms, pain,
opioids use, spiritual
needs, grief.
Whole patient
assessment should
include physical,
psychosocial, and
spiritual dimensions,
according to the
nature of the illness.
Recommendations on
how to assess patients
and how to deal with
their physical,
emotional,
psychological, social
and spiritual issues.
Holistic approach:
physical, psychological,
social, practical and
emotional, religious and
spiritual support.
Holistic approach:
physical, psychological,
social, emotional and
spiritual support. Use of
the Gold Standard
Framework (GSF).
Timing for holistic
assessments
Not included assessment takes
place at the first
appointment. Further
assessments depends
on changes in the
disease trajectory.
Whenever the patient is
seen by the GP or nurse
using the ‘distress
thermometer’.
At any time of day or
night for physical and
psychological support
and as long as possible
for the social
participation.
At any time of day or
night for physical and
psychological support
and as long as possible
for the social
participation.
Timing for PC
introduction
Interventions based
on the patients &their
family’s needs. PC
services should be
guaranteed when
necessary.
Not included Surprise Question:
“Would you be
surprised if your patient
were to die in the next
months, weeks, days?”.
Ask the Surprise
Question “Would you be
surprised if the patient
were to die in the next
months, weeks or
days?”.
Timely access to
generalist and specialist
PC services on the basis
of need and not
diagnosis.
Patient’s goals
assessments
Decision-making should
be enhanced through
the life goals and
personal values.
Patient’s goals for
care should be
brought to light.
At the time of the
holistic assessment,
patients goals need to
be assessed too.
Regular review of
patients’ and carers’
needs and preferences.
Open conversations and
clear expression of the
end-of-life patients and
their needs.
Continuous goal
adjustment.
Needs on information
and preferences of the
patient should be
assessed regularly.
Patients have the
right for modifying
the plan based
according to their
needs. Interventions
should be adapted to
patient’s goals.
Whenever there are
changes in the disease
trajectory patients goals
need to be reassessed.
Discussions with
patients and their carers
about their future needs.
This should be done as
often as it feels that is
needed.
Patients and carers
should be offered
holistic assessments in
response to their
changing needs and
preferences.
Suffering
reduction
Evaluation of the pain,
instructions and
involvement of patient
in the use of analgesics
and opioids depending
of the pain stage and
features.
Medical aspect of PC
& applicable
therapies, special
treatments &
interventions to
reduce suffering
(physical, psychosocial
symptoms).
Based on an overview
of needs of PC patients
(study done by the
Federal Knowledge
Center), several caring
goals to reduce
suffering are given.
Should meet physical
and psychological needs
at any time of day or
night, including access
to medicines and
equipment.
End of life patients
should have their
physical and
psychological needs
met at any time of day
or night, including
access to medicines
and equipment.
Advance care
planning (ACP).
Explore patient’s wishes
and goals. Previous
guidelines, wishes of the
patient saved in his
clinical records, legal
and the nearest in
charge relatives should
be considered.
Patients have the
right to information
and autonomy/self-
determination, refusal
of treatments, & the
process of making a
living will
ACP can be done
through 3 models
(Covenant model,
contract model or DNR
code) and there are
guidelines for urgent
and non-urgent ACP.
Help the patients
identify the choices that
they may face, assist
them to record their
decisions and ensure
that their wishes are
fulfilled. Recognition of
wishes for resuscitation,
organ donation and
place of death.
Increasing choice and
personalization through
ACP including advance
decisions to refuse
treatment and provision
of resources that enable
these choices.
Involvement of PC
team.
Training of professionals
to provide basic PC
should be promoted; PC
at any level should be
provided preferably, by a
multi-disciplinary team.
Implemented by a
multi-disciplinary
team; physicians,
nurses, psychologists,
mental health coun
sellors, social workers,
clergymen.
If prognosis of <12 m,
a multidisciplinary
consultation will be
organized between
different health care
professionals including
PC.
Multidisciplinary
generalist and specialist
PC services should
provide care over a 24
h period for people
approaching the end
of life.
Specialist multidisciplinary
PC team should be
responsive to emergency
need and able to admit
people approaching
the end of life at any
time
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Table 5 Top 5 ICP guidelines and pathways (Continued)
Recommendations
on care during the
last hours of living.
Recommendations
include information,
explanations, symptoms
treatment, care
continuity and holistic
approach.
Symptoms and signs
of death, reducing
medication, nutrition,
and fluid intake
during the last hours
of life.
Contains a separate
section on how to
identify the dying
phase, communication,
support, symptom
control.
Identification of the
dying phase (use of
Patient Charter). Support
for patient and carer.
Use of the Liverpool
Care Pathway.
Co-ordinated care across
all relevant settings at
any time, based on the
person’s current medical
condition, advance care
planning and
preferences.
Grief and
bereavement care
recommendations.
Identification of
bereavement risk;
interventions according
to the nature of the
grief, with professionals
trained to deal with
these issues.
Methods, aims and
outcomes of
bereavement
counselling are
described in the
guideline.
Consultation after
death, differentiation
between depression,
normal and
complicated grief.
Timely verification and
certification of death.
Practical and emotional
bereavement support
for carer or family.
Immediate and ongoing,
emotional, bereavement
& spiritual support as
appropriate to the needs
and preferences of the
carer/family.
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and family’s needs and wishes and symptom control.
11)Grief and bereavement care: The main proposed
strategy involves the immediate and ongoing
bereavement, emotional and spiritual support
appropriate to the family’s needs and preferences.
The point at which PC should be introduced in the
disease trajectory and which referral criteria should
apply was addressed in less than half of the total of the
included guidelines and pathways. This could be seen to
have a significant impact on the benefits of PC if not in-
troduced to patients in a timely manner. In view of this,
it is surprising that 59 % (n = 43) of all the included
guidelines/pathways did not discuss (adequately or at all)
referral criteria.
The distribution of the guidelines/pathways that expli-
citly mentioned the referral criteria shows that 8 % rec-
ommended that the referral criterion should be for
terminally ill people without specifying the exact timing.
Further, 7 % reported that the referral criteria should be
located in the last 6 months. Also, 4 % of the guidelines
reported as a referral criterion the surprise question
(“Would I be surprised if this patient died in the next
year?”) whereas 8 % the reference of fulfilment of spe-
cific prognostic criteria mentioned in the Gold Standards
Framework or Stadium IVB [106, 107]. The presence of
metastatic disease was considered as a referral criterion
by 15 % of all the studies whilst 13 % suggested the ap-
plication of the guidelines as soon as the diagnosis of
cancer has been made. Finally, one guideline recom-
mended that the referral criteria should be determined
upon a discussion with the patient and the family.
Discussion
The results of the systematic review identified 74
guidelines/pathways fulfilling our inclusion criteria.
Geographically, the majority of the included studies
originated from the UK. Moreover, only five of them
scored at least 10/11 of the IPC criteria.Although there is significant improvement in cancer
treatment, still half of all patients with cancer will even-
tually die of their disease and in one third this will hap-
pen within 6 months of diagnosis [108]. Currently,
European and American oncology organisations such as
ASCO, ESMO, and NCCN, recommend the early inte-
gration of PC for patients with cancer [2, 109]. These
recommendations have been evidenced by studies that
corroborate the positive relationship between early inte-
gration of PC and improvements in the quality of life of
the patients, leading to better patient and caregiver out-
comes, improvement of symptoms and patient satisfac-
tion, with reduced caregiver burden, and reduced use of
futile interventions [3, 12, 110–112]. Despite this evi-
dence, cancer patients tend to be referred to PC late in
their disease trajectory [12]. The implementation of PC
integration is highly dependent on staff perception (mis-
conception) of PC that often gets mistaken for terminal
care [113].
The guidelines and pathways made a number of rec-
ommendations about how to introduce pc into oncology
care. These included recommendations on how PC can
be implemented earlier in oncology care are education
of providers and public about the importance of PC and
to coordinate PC efforts through strengthening affilia-
tions and/or developing new partnerships [114]. One
way to educate clinicians would be the integration of PC
in disease specific guidelines.
According to our findings, most of the included
guidelines/pathways recommend the need of a holistic
PC approach e.g. a whole patient assessment. Add-
itionally, it is also recognised that the reduction of
suffering by implementing specific PC interventions
e.g. use of opioids or analgesics, should be among the
primary goals of integrated PC. This is in agreement
with empirical evidence that illustrate the advantages
of both the holistic approach and the focus on the
reduction of suffering [115, 116].
A noteworthy outcome has been the general shortage
in the guidelines of information on the specification on
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Moreover, even among those guidelines/pathways that
comment on the timing of referral, there is great vari-
ability e.g. surprise question, life expectancy less than
6 months, presence of metastatic disease, etc. We
consider this important because clear referral criteria
enable the initiation of the guideline/pathway. Conse-
quently, this is correlated with the overall efficiency of
a guideline/pathway. The notable absence of references
to the referral criteria and the strong disagreement
between those that mention them deserve further
exploration.
More generally, there is a growing recognition that the
PC should be considered around the time of diagnosis
[117]. However, available research hints that that these
recommendations alone are not sufficient for the prac-
tical determination of the referral criteria [118, 119].
With regard to cancer, a robust definition of the referral
criteria is quite cumbersome and detailed and systematic
methods need further development [113]. NCCN states
that all patients should be screened for PC needs at their
initial visit, at appropriate intervals and as clinically indi-
cated [8]. For ASCO’s Panel’s expert consensus com-
bined standard oncology care and palliative care should
be considered early in the course of illness for any pa-
tient with metastatic cancer and/or high symptom bur-
den [12]. In Germany, Gaertner et al. developed
diagnosis specific guidelines for 19 malignancies to iden-
tify a disease- specific point in each disease trajectory to
initiate palliative care [11]. In view of the above, we con-
clude that the establishment of PC referral criteria in
guidelines for cancer patients remains an elusive and
contentious topic which demands further attention.
Interestingly, guidelines/pathways give less attention
to advance care planning, grief and bereavement sup-
port for the family members, and continuity of care.
This outcome is surprising because the significance of
these aspects has been highlighted by several studies
[9, 120, 121]. Oncologists have to give their patients
clear and consistent prognostic information as this
will help facilitate discussions about patients’ end of
life care preferences. Fears among oncologists that early
PC consultation will frighten their patients are unfounded
and the opposite has been proven [122]. Oncologists must
ensure that advance care plans are in place as early as
possible in the disease trajectory [8]. Bereavement support
is gaining attention in the oncology field, with the NCCN
guidelines being the first guideline that sees after-
death care for the family as an essential part of the
continuum of cancer care [8].
With the exception of the referral criteria, the holistic
approach and the reduction of suffering, the compli-
ance with Emmanuel’s IPC criteria of the included
guidelines/pathways varies widely. In turn, this impliesthat the fulfilment of integrated PC criteria is generally
not taken into consideration when designing cancer
guidelines/pathways. Previous studies looking at End-of-
Life care content in medical textbooks and in treatment
guidelines for life-limiting disease already revealed
that top-selling textbooks and guidelines on chronic,
life-limiting illnesses offer little information on caring
for patients at the end of life [123]. Our findings
reveal that five of the guidelines/pathways fulfilled at
least 10 out of 11 IPC criteria (in fact three fulfilled
all 11 criteria).
A closer look at the content of these guidelines has
shown that they offer similar recommendations on IPC
(Table 5). This has a three-fold importance. First it af-
firms that these five guidelines can serve as a benchmark
for PC integration in cancer guidelines. Second, it hints
that for all the guidelines/pathways that scored moder-
ately or low, there is a considerable room for improve-
ment. Finally, it supports the appropriateness of using
Emanuel’s tool for the evaluation of the PC content of
guideline data.
To conclude, it can be inferred that, even though small
discrepancies do exist, the strategies proposed by the
guidelines/pathways that scored the highest have strong
content similarity. In turn, this suggests that there is a
common conception concerning the incorporation of in-
tegrated PC into the framework for guidelines/pathways.
Finally, it is important to reiterate that we should dif-
ferentiate between the completeness of guidelines/path-
ways content and its performance following its clinical
implementation. Although a correlation between the two
is quite likely to exist, a high score with respect to
Emmanuel’s criteria cannot be considered to necessarily
speculate on the efficacy of the guidelines/pathways in
the clinical context. Future research could explore the
clinical utility of these top guidelines/pathways.Study limitations
As is the case with any study that aspires to conduct a
systematic literature review, a major limitation stems
from the choice of the search strategy. We started with a
broad search not only focussing on cancer but also on
chronic disease. The results of the latter will be the sub-
ject of a subsequent article. More specifically, the search
of the electronic databases returned a large amount of
articles, many of which originated outside Europe.
In general, there is a lack of standardised definitions
regarding integrated PC [8]. For the needs of this study,
we furnished our own functional definition. However,
our results might differ if a different definition had been
employed.
An additional limitation stems from the confinement
to guidelines/pathways published in Dutch, English,
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may not exclude the possibility that more guidelines and
pathways exist in other languages spoken in the EU.
As mentioned above, the evaluation of the content of
the guidelines/pathways used Emmanuel’s criteria. The
authors of this study, in collaboration with all the InSup-
C project partners, decided to use this tool on the basis
of its apparent completeness. Therefore, one may not
exclude the possibility that a different assessment tool
would lead to a different score of the guidelines/path-
ways and thus a different hierarchy. Additionally, we
only performed a limited analysis of the content of rec-
ommendations of IPC based on the most complete
guidelines for PC according to Emmanuel’s criteria.
Finally, the fact that we included only guidelines that
included only two or more of the 11 Emanuel’s IPC cri-
teria might have skewed the results favouring a more
positive view of integration of PC in oncology care in
Europe.Conclusions
Five studies were found to fulfil at least 10/11 of the IPC
criteria for completeness on IPC. These guidelines/path-
ways proposed very similar strategies for the realization
of these criteria and were based on high levels of evi-
dence. Consequently, they could serve as benchmarks of
how PC can be integrated in cancer guidelines. As such,
they also can provide a base to further investigate what
constitutes integrated PC in cancer.
Our systematic review has revealed the importance of
a holistic approach and interventions aimed at reducing
suffering by deploying an integrated palliative care ap-
proach. Additionally, our results illustrate that there is
disagreement on the appropriate referral criteria for IPC
which remains a contentious and challenging topic in
terms of the integration of PC in cancer care.
As mentioned above, the included guidelines/pathways
do not embody aspects of implementation. Therefore,
even though the theoretical framework of these guide-
lines/pathways conforms reasonably well to the state of
the art in IPC, their applicability in practice needs to be
further investigated.
Overall, our findings have identified both the strengths
and the weaknesses of the available guidelines and path-
ways in Europe for patients with cancer in terms of the
integration of palliative care. Consequently, we antici-
pate that our findings may inform physicians and policy
makers as a framework in their efforts to improve the
integration of PC in the care of people with cancer.Ethics/research governance approval
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